Prognostic significance of expression of VEGF and Cox-2 in nasopharyngeal carcinoma and its association with expression of C-erbB2 and EGFR

J Surg Oncol. 2011 Jan 1;103(1):46-52. doi: 10.1002/jso.21767.

Abstract

Background and objectives: This study evaluated several tumor angiogenesis-related markers to examine their expression pattern and relation to clinicopathologic implications of nasopharyngeal carcinoma.

Methods: Paraffin sections from 69 nasopharyngeal carcinomas obtained before radiotherapy were prepared. The expression of vascular endothelial growth factor (VEGF), cyclooxygenase-2 (Cox-2), C-erbB2, and epidermal growth factor receptor (EGFR) were investigated by immunohistochemistry and then correlated with various clinicopathologic parameters.

Results: VEGF was inversely correlated with C-erbB2 (P = 0.036). In survival analysis, high mitosis (≥5/10 high power field) was significantly associated with worse relapse-free survival in univariate analysis (P = 0.048) but not in multivariate analysis (P = 0.153). High stage, high mitotic rate, absence of VEGF, and presence of Cox-2 were associated with worse survival in both univariate analysis (P = 0.002, P = 0.038, P = 0.044, and P = 0.028, respectively) and multivariate analysis (P = 0.007, P = 0.036, P = 0.047, and P = 0.004, respectively).

Conclusions: Absence of VEGF is a useful indicator of poor prognosis in addition to Cox-2 expression, high stage, and high mitosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Biomarkers, Tumor / metabolism*
  • Carcinoma
  • Cyclooxygenase 2 / metabolism*
  • ErbB Receptors / metabolism*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mitosis
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Neoplasms / metabolism
  • Nasopharyngeal Neoplasms / mortality
  • Prognosis
  • Receptor, ErbB-2 / metabolism*
  • Survival Analysis
  • Vascular Endothelial Growth Factor A / metabolism*
  • Young Adult

Substances

  • Biomarkers, Tumor
  • Vascular Endothelial Growth Factor A
  • Cyclooxygenase 2
  • ErbB Receptors
  • Receptor, ErbB-2